FUCHS
Clinical trials for FUCHS explained in plain language.
Never miss a new study
Get alerted when new FUCHS trials appear
Sign up with your email to follow new studies for FUCHS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stanford tests new approach to save vision in common eye disease
Disease control Recruiting nowThis study compares two surgical approaches for Fuchs endothelial dystrophy, an eye condition that causes cloudy vision. Researchers are testing whether a less invasive procedure (Descemet Stripping Only with Ripasudil eye drops) works as well as the standard transplant surgery (…
Matched conditions: FUCHS
Phase: PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Experimental eye drops aim to target genetic cause of blinding corneal disease
Disease control Recruiting nowThis study is testing an experimental eye drop called DT-168 in patients with Fuchs Endothelial Corneal Dystrophy (FECD), a genetic eye disease that can cause vision loss and often requires a corneal transplant. The main goal is to see if the drops can affect the underlying genet…
Matched conditions: FUCHS
Phase: PHASE2 • Sponsor: Design Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC